| Little Falls Eye Care Center P.a. | |
| 313 1st St Se, Little Falls, Minnesota 56345 | |
| (320) 632-3676 |
| Name | Little Falls Eye Care Center P.a. |
|---|---|
| Organization Name | Little Falls Eye Care Center Pa |
| Location | 313 1st St Se, Little Falls, Minnesota 56345 |
| Type | Supplier |
| Phone | (320) 632-3676 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
Researchers from Mount Sinai School of Medicine have developed a new computational method that will make it easier for scientists to identify and prioritize genes, drug targets, and strategies for repositioning drugs that are already on the market. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions. The new algorithm will also help scientists identify fellow researchers with whom they can collaborate.
Spirus Medical, Inc., a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, announced at Digestive Disease Week 2010 that results from the first-ever prospective study comparing enteroscopy technologies show spiral enteroscopy (SE) to be more than three times faster, on average, than double-balloon enteroscopy (DBE) in examining the small intestine.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Chinese men are selectively switching from traditional Chinese medicine (TCM) to Viagra to treat erectile dysfunction, but sticking with tradition for ailments such as arthritis, indigestion and gout, according to new research published in Environmental Conservation.
› Verified 1 days ago
News Archive
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
Researchers from Mount Sinai School of Medicine have developed a new computational method that will make it easier for scientists to identify and prioritize genes, drug targets, and strategies for repositioning drugs that are already on the market. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions. The new algorithm will also help scientists identify fellow researchers with whom they can collaborate.
Spirus Medical, Inc., a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, announced at Digestive Disease Week 2010 that results from the first-ever prospective study comparing enteroscopy technologies show spiral enteroscopy (SE) to be more than three times faster, on average, than double-balloon enteroscopy (DBE) in examining the small intestine.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Chinese men are selectively switching from traditional Chinese medicine (TCM) to Viagra to treat erectile dysfunction, but sticking with tradition for ailments such as arthritis, indigestion and gout, according to new research published in Environmental Conservation.
› Verified 1 days ago
Baby's On Broadway Type: DME Supplier - Customized Equipment Location: 47 E Broadway, Little Falls, Minnesota 56345 Phone: (320) 639-2229 | |
Coborn's Pharmacy Type: Long Term Care Pharmacy Location: 1105 2nd Ave Ne, Little Falls, Minnesota 56345 Phone: (320) 632-2380 | |
Falls Optical Inc Type: Medicare Supplier Location: 1850 1st Ave Ne, Little Falls, Minnesota 56345 Phone: (320) 632-2391 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 211 1st St Se, Little Falls, Minnesota 56345 Phone: (320) 632-3661 | |
Little Falls Eye Care Center P.a. Type: Medicare Supplier Location: 313 1st St Se, Little Falls, Minnesota 56345 Phone: (320) 632-3676 |